During the past decade, Gastro Center of Maryland conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 17 clinical trials were completed, i.e. on average, 53.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 16 clinical trials were completed. i.e. 123.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Gastro Center of Maryland" #1 sponsor was "Pfizer" with 6 trials, followed by "Allergan" with 4 trials sponsored, "Galapagos NV" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Gastro Center of Maryland" #1 collaborator was "Galapagos NV" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Gastro Center of Maryland" are "Ulcerative Colitis" (8 trials), "Crohn's Disease" (4 trials), "Gastroparesis" (4 trials), "Colorectal Cancer" (3 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Gastro Center of Maryland" in a lesser frequency.

Most popular intervention types in "Gastro Center of Maryland" are "Drug" (29 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Filgotinib" (7 trials), "Etrasimod" (3 trials), "Placebo to match filgotinib" (3 trials) and "Relamorelin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Gastro Center of Maryland" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Gastro Center of Maryland". undefined are not yet recruiting, 10 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Gastro Center of Maryland, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Gastro Center of Maryland, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".